ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Avastin Increases Overall Survival 3.7 Months

February 22, 2013

Huebner Retires, Named Scientist Emeritus

November 19, 1982

Trials Suspended At Oklahoma Over Study Of Cancer Vaccine.

July 14, 2000

Ethics Commission To Take Up Again Compensation Issue

September 11, 1981

Pas Available; Alternative Medicine

January 21, 1994

NCI Advisory Group, Other Cancer Meetings

August 30, 1991